Literature DB >> 26781822

Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.

Trilokesh D Kidambi1, Amie Blanco2, Jessica Van Ziffle3, Jonathan P Terdiman4,5,6.   

Abstract

At least one-third of patients meeting clinical criteria for Lynch syndrome will have no germline mutation and constitutional epimutations leading to promoter methylation of MLH1 have been identified in a subset of these patients. We report the first case of constitutional MLH1 promoter methylation associated with a colonic polyposis syndrome in a 39 year-old man with a family history of colorectal cancer (CRC) and a personal history of 21 polyps identified over 8 years as well as the development of two synchronous CRCs over 16 months who was evaluated for a hereditary cancer syndrome. Immunohistochemistry (IHC) of multiple tumors showed absent MLH1 and PMS2 expression, though germline testing with Sanger sequencing and multiplex ligation-dependent probe amplification of these mismatch repair genes (MMR) genes was negative. A next generation sequencing panel of 29 genes also failed to identify a pathogenic mutation. Hypermethylation was identified in MLH1 intron 1 in tumor specimens along with buccal cells and peripheral white blood cells, confirming the diagnosis of constitutional MLH1 promoter methylation. This case highlights that constitutional MLH1 methylation should be considered in the differential diagnosis for a polyposis syndrome if IHC staining shows absent MMR gene expression.

Entities:  

Keywords:  Epimutation; Hereditary colon cancer; Lynch syndrome; MLH1; Polyposis; Promoter hypermethylation

Mesh:

Substances:

Year:  2016        PMID: 26781822     DOI: 10.1007/s10689-016-9868-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

Review 1.  Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility.

Authors:  Megan P Hitchins
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

Review 2.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

3.  Mosaic Epigenetic Inheritance as a Cause of Early-Onset Colorectal Cancer.

Authors:  Mathew A Sloane; Andrea C Nunez; Deborah Packham; Chau-To Kwok; Graeme Suthers; Luke B Hesson; Robyn L Ward
Journal:  JAMA Oncol       Date:  2015-10       Impact factor: 31.777

Review 4.  Epigenetic mechanisms in the pathogenesis of Lynch syndrome.

Authors:  P Peltomäki
Journal:  Clin Genet       Date:  2014-02-17       Impact factor: 4.438

5.  Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers.

Authors:  Kathleen M Murphy; Shengle Zhang; Tanya Geiger; Michael J Hafez; Jeff Bacher; Karin D Berg; James R Eshleman
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 6.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

7.  Defining the adenoma burden in lynch syndrome.

Authors:  Matthew F Kalady; Sara E Kravochuck; Brandie Heald; Carol A Burke; James M Church
Journal:  Dis Colon Rectum       Date:  2015-04       Impact factor: 4.585

8.  Risk of cancer in cases of suspected lynch syndrome without germline mutation.

Authors:  María Rodríguez-Soler; Lucía Pérez-Carbonell; Carla Guarinos; Pedro Zapater; Adela Castillejo; Victor M Barberá; Miriam Juárez; Xavier Bessa; Rosa M Xicola; Juan Clofent; Luis Bujanda; Francesc Balaguer; Josep-Maria Reñé; Luisa de-Castro; José C Marín-Gabriel; Angel Lanas; Joaquín Cubiella; David Nicolás-Pérez; Alejandro Brea-Fernández; Sergi Castellví-Bel; Cristina Alenda; Clara Ruiz-Ponte; Angel Carracedo; Antoni Castells; Montserrat Andreu; Xavier Llor; José L Soto; Artemio Payá; Rodrigo Jover
Journal:  Gastroenterology       Date:  2013-01-24       Impact factor: 22.682

9.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.

Authors:  Francis M Giardiello; John I Allen; Jennifer E Axilbund; C Richard Boland; Carol A Burke; Randall W Burt; James M Church; Jason A Dominitz; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David A Lieberman; Douglas J Robertson; Sapna Syngal; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2014-07-22       Impact factor: 10.864

10.  Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry.

Authors:  Robyn L Ward; Timothy Dobbins; Noralane M Lindor; Robert W Rapkins; Megan P Hitchins
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822

View more
  6 in total

Review 1.  Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.

Authors:  Megan P Hitchins
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

Review 2.  Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.

Authors:  Pere Llinàs-Arias; Manel Esteller
Journal:  Open Biol       Date:  2017-09       Impact factor: 6.411

Review 3.  Lynch-like Syndrome: Potential Mechanisms and Management.

Authors:  Alejandro Martínez-Roca; Mar Giner-Calabuig; Oscar Murcia; Adela Castillejo; José Luis Soto; Anabel García-Heredia; Rodrigo Jover
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

4.  Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis.

Authors:  Takashi Takeda; Kouji Banno; Megumi Yanokura; Masataka Adachi; Moito Iijima; Haruko Kunitomi; Kanako Nakamura; Miho Iida; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Wataru Yamagami; Akira Hirasawa; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

Review 5.  DNA methylation detection methods used in colorectal cancer.

Authors:  Yu-Xia Zhan; Guang-Hua Luo
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

6.  Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period.

Authors:  Jordyn Silverstein; Wesley Kidder; Susan Fisher; Thomas A Hope; Samantha Maisel; Dianna Ng; Jessica Van Ziffle; Chloe E Atreya; Katherine Van Loon
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.